Klinične študije za Migrena v Nebraska
8 študij za Migrena išče udeležence na lokacijah v Nebraska.
Mesta v Nebraska
Uradno besedilo študije (angleško)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital & Medical Center, Omaha
Vključevanje udeležencevFaza 1
Starost 6–11 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Grand Island, Grand Island
- Papillion Research Center/CCT Research, Papillion
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's Hospital & Medical Center, Omaha
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's Hospital & Medical Center, Omaha
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Cct Research - Papillion Research Center /ID# 270393, Papillion
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nebraska Medical Center, Omaha
Vključevanje udeležencevFaza 4
Starost 18–70 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Cognitive Clinical Trials (CCT) - Papillion /ID# 232552, Papillion
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05125302Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Tri City Research Center, LLC /ID# 278800, Grand Island
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 10. feb. 2026 · NCT07310290Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.